FDA Maps Out Potential 510(k) Reforms In Long-Awaited Report

FDA released its highly anticipated proposals for reforming the 510(k) program last week, and industry reps acknowledged that many of the individual recommendations could benefit companies

More from Archive

More from Medtech Insight